Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 27.27 percent decrease over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $67.80 million which beat the analyst consensus estimate of $66.82 million by 1.47 percent. This is a 6.75 percent increase over sales of $63.51 million the same period last year.
Tevva Motors Announced It Will Seek Legal Recourse Following ElectraMeccanica Termination Of Proposed Merger Agreement
Earlier this month (4 October 2023), Tevva Motors Limited (Tevva) was informed by ElectraMeccanica Vehicles Corp. (ElectraMeccanica) that it no longer intended to continue with the merger agreement, citing
